Search Results for: PTEN

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel FBL fibrillarin
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
Novel FBXW11 F-box and WD repeat domain containing 11
  • Activation of NF-kappaB in B cells
  • Downstream TCR signaling
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • NIK-->noncanonical NF-kB signaling
  • MAP3K8 (TPL2)-dependent MAPK1/3 activation
  • Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Degradation of CRY and PER proteins
Novel FGF7 fibroblast growth factor 7
  • PI3K Cascade
  • PIP3 activates AKT signaling
  • FGFR2b ligand binding and activation
  • Activated point mutants of FGFR2
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Phospholipase C-mediated cascade; FGFR2
  • PI-3K cascade:FGFR2
  • SHC-mediated cascade:FGFR2
  • FRS-mediated FGFR2 signaling
  • Negative regulation of FGFR2 signaling
  • Signaling by FGFR2 in disease
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Developmental Lineage of Multipotent Pancreatic Progenitor Cells
Novel FLNA filamin A
  • Platelet degranulation
  • GP1b-IX-V activation signalling
  • Cell-extracellular matrix interactions
  • RHO GTPases activate PAKs
  • OAS antiviral response
  • Artenimol
  • FG syndrome (FGS); Opitz-Kaveggia syndrome
  • Periventricular nodular heterotopia (PVNH)
  • Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
  • Fronto-Otopalatodigital Osteodysplasia, including: Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Melnick-Needles syndrome; Frontometaphyseal dysplasia
Novel FOXK1 forkhead box K1
  • UCH proteinases
Novel FUBP3 far upstream element binding protein 3
Novel GEMIN4 gem nuclear organelle associated protein 4
  • snRNP Assembly
  • SARS-CoV-2 modulates host translation machinery
Novel GNAI1 G protein subunit alpha i1
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • ADP signalling through P2Y purinoceptor 12
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Regulation of insulin secretion
  • Extra-nuclear estrogen signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • Guanosine-5'-Diphosphate
  • Tetrafluoroaluminate Ion
Novel GNAI2 G protein subunit alpha i2
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • ADP signalling through P2Y purinoceptor 12
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Regulation of insulin secretion
  • Extra-nuclear estrogen signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • Adrenal carcinoma
Novel GNB4 G protein subunit beta 4
  • Activation of G protein gated Potassium channels
  • Glucagon signaling in metabolic regulation
  • G-protein activation
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 12
  • G beta:gamma signalling through PI3Kgamma
  • Prostacyclin signalling through prostacyclin receptor
  • Prostacyclin signalling through prostacyclin receptor
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Ca2+ pathway
  • Ca2+ pathway
  • G alpha (q) signalling events
  • G alpha (12/13) signalling events
  • G beta:gamma signalling through PLC beta
  • G alpha (s) signalling events
  • ADP signalling through P2Y purinoceptor 1
  • ADP signalling through P2Y purinoceptor 1
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Glucagon-type ligand receptors
  • Thromboxane signalling through TP receptor
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
  • G beta:gamma signalling through BTK
  • G beta:gamma signalling through CDC42
  • Extra-nuclear estrogen signaling
  • GPER1 signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
Novel GNL3 G protein nucleolar 3
  • Major pathway of rRNA processing in the nucleolus and cytosol
Novel GPC4 glypican 4
  • Glycosaminoglycan-protein linkage region biosynthesis
  • HS-GAG biosynthesis
  • HS-GAG biosynthesis
  • HS-GAG degradation
  • Defective B4GALT7 causes EDS, progeroid type
  • Defective B3GAT3 causes JDSSDHD
  • Defective EXT2 causes exostoses 2
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Defective B3GALT6 causes EDSP2 and SEMDJL1
  • Attachment and Entry
  • Attachment and Entry
  • Retinoid metabolism and transport
  • Respiratory syncytial virus (RSV) attachment and entry
  • RSV-host interactions
Novel GSTM2 glutathione S-transferase mu 2
  • Glutathione conjugation
  • Glutathione
  • S-(2,4-dinitrophenyl)glutathione
  • Glutathione disulfide
  • Glutathione disulfide
  • Deoxycholic acid
  • S-Methyl glutathione
Novel GTF3C2 general transcription factor IIIC subunit 2
  • RNA Polymerase III Abortive And Retractive Initiation
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
Novel GTF3C3 general transcription factor IIIC subunit 3
  • RNA Polymerase III Abortive And Retractive Initiation
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
Novel GTF3C5 general transcription factor IIIC subunit 5
  • RNA Polymerase III Abortive And Retractive Initiation
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
Novel H2AC4 H2A clustered histone 4
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Pre-NOTCH Transcription and Translation
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • PRC2 methylates histones and DNA
  • Condensation of Prophase Chromosomes
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • DNA Damage/Telomere Stress Induced Senescence
  • HDACs deacetylate histones
  • HATs acetylate histones
  • HATs acetylate histones
  • RMTs methylate histone arginines
  • SIRT1 negatively regulates rRNA expression
  • ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
  • NoRC negatively regulates rRNA expression
  • NoRC negatively regulates rRNA expression
  • B-WICH complex positively regulates rRNA expression
  • DNA methylation
  • Transcriptional regulation by small RNAs
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
  • UCH proteinases
  • Ub-specific processing proteases
  • Metalloprotease DUBs
  • Deposition of new CENPA-containing nucleosomes at the centromere
  • Assembly of the ORC complex at the origin of replication
  • RNA Polymerase I Promoter Opening
  • RNA Polymerase I Promoter Escape
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Estrogen-dependent gene expression
  • Meiotic recombination
  • HCMV Early Events
  • HCMV Late Events
  • Transcriptional regulation of granulopoiesis
  • Inhibition of DNA recombination at telomere
  • Defective pyroptosis
  • Negative Regulation of CDH1 Gene Transcription
  • Amyloid fiber formation
  • Chromatin modifications during the maternal to zygotic transition (MZT)
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
  • Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
  • Regulation of PD-L1(CD274) transcription
Novel H2AX H2A.X variant histone
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Pre-NOTCH Transcription and Translation
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • PRC2 methylates histones and DNA
  • Condensation of Prophase Chromosomes
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • DNA Damage/Telomere Stress Induced Senescence
  • RMTs methylate histone arginines
  • SIRT1 negatively regulates rRNA expression
  • ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
  • NoRC negatively regulates rRNA expression
  • NoRC negatively regulates rRNA expression
  • B-WICH complex positively regulates rRNA expression
  • DNA methylation
  • Transcriptional regulation by small RNAs
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Nonhomologous End-Joining (NHEJ)
  • Processing of DNA double-strand break ends
  • Deposition of new CENPA-containing nucleosomes at the centromere
  • Assembly of the ORC complex at the origin of replication
  • G2/M DNA damage checkpoint
  • RNA Polymerase I Promoter Opening
  • RNA Polymerase I Promoter Escape
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Estrogen-dependent gene expression
  • Meiotic recombination
  • Transcriptional regulation of granulopoiesis
  • Inhibition of DNA recombination at telomere
  • Defective pyroptosis
  • Negative Regulation of CDH1 Gene Transcription
  • Amyloid fiber formation
  • Chromatin modifications during the maternal to zygotic transition (MZT)
  • Replacement of protamines by nucleosomes in the male pronucleus
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
  • Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex
  • Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
  • Regulation of PD-L1(CD274) transcription
Novel HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
  • Acyl chain remodeling of CL
  • Beta oxidation of myristoyl-CoA to lauroyl-CoA
  • mitochondrial fatty acid beta-oxidation of unsaturated fatty acids
  • Beta oxidation of palmitoyl-CoA to myristoyl-CoA
  • Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA
  • Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA
  • Beta oxidation of octanoyl-CoA to hexanoyl-CoA
  • Beta oxidation of hexanoyl-CoA to butanoyl-CoA
  • NADH
  • Disorders of fatty-acid oxidation, including: Medium-chain (MC) acyl-CoA dehydrogenase (AD) deficiency (MCADD); Short-chain AD deficiency (SCADD) ; Short-branched-chain AD deficiency (SBCADD) ; Very long-chain AD deficiency (VLCADD) ; Long-chain 3-hydroxyacyl CoA dehydrogenase deficiency (LCHADD) ; Trifunctional protein deficiency (TFP); Carnitine palmitoyltransferase deficiency (CPT); Carnitine-acylcarnitine translocase deficiency (CACT); Systemic primary carnitine deficiency (CDSP)
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
Novel HBA1 hemoglobin subunit alpha 1
  • Erythrocytes take up carbon dioxide and release oxygen
  • Erythrocytes take up oxygen and release carbon dioxide
  • Scavenging of heme from plasma
  • Cytoprotection by HMOX1
  • Heme signaling
  • Heme assimilation
  • Iron Dextran
  • Iron
  • Zinc
  • 4-Carboxycinnamic Acid
  • Pentaerythritol tetranitrate
  • 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine
  • 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine
  • Sebacic acid
  • 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID
  • 2,6-dicarboxynaphthalene
  • Efaproxiral
  • Trimesic acid
  • Nitrous acid
  • Copper
  • Ferric pyrophosphate
  • Sodium ferric gluconate complex
  • Ferrous sulfate anhydrous
  • Ferric pyrophosphate citrate
  • Zinc acetate
  • Ferrous gluconate
  • Ferrous succinate
  • Ferrous ascorbate
  • Ferrous fumarate
  • Ferrous glycine sulfate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Voxelotor
  • Ferric derisomaltose
  • Thalassemia; Alpha thalassemia; Beta thalassemia; Alpha thalassemia, X-linked (ATRX)

Page 6 out of 39 pages